All companies
Clarivate logo

What smart money is saying about ClarivateUnited Kingdom flag

CLVT · Technology · Information Technology Services · Market cap $940M

1 fund in our archive has pitched Clarivate — most recently Exor in June 2026.

Company profile

Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.

Get an email when a fund writes about it

Summarize with Warren AI
1
Reported positions
0
Bought
0
Sold
1
Letter

Position history

Every position in Clarivate on record in the archive was reported in Q2 2026, across 1 fund letter, with no move described.

Fund letters reporting a position in Clarivate, by quarter
QuarterLettersBoughtSoldTheses
Q2 20261001

Fund activity · 1 position

  • HoldsExor
    June 2026
    “CLARIVATE €0.1bnSHAREHOLDING VALUE 0.4%% OF GAV 10.5%ECONOMIC RIGHTS Leading global provider of transformative intelligence Clarivate is a provider of intelligence solutions, offering enriched data, analytics, and workflow tools across academia, intellectual property, and the life sciences space.”
    Clarivate

Fund coverage · 1 thesis

  • Exor
    June 2026

    Clarivate provides mission-critical intelligence solutions with high switching costs and durable growth potential.

    Read the full thesis

Read every full thesis on Clarivate

Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans→
Share this ledger